BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1697754)

  • 1. Bidirectional regulation of cAMP generating system by dopamine-D1 and D2-receptors in the rat retina.
    Nowak JZ; Sek B; Schorderet M
    J Neural Transm Gen Sect; 1990; 81(3):235-40. PubMed ID: 1697754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal dopamine D1 and D2 receptors: characterization by binding or pharmacological studies and physiological functions.
    Schorderet M; Nowak JZ
    Cell Mol Neurobiol; 1990 Sep; 10(3):303-25. PubMed ID: 2174740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dark-induced supersensitivity of dopamine D-1 and D-2 receptors in rat retina.
    Nowak JZ; Sek B; Schorderet M
    Neuroreport; 1991 Aug; 2(8):429-32. PubMed ID: 1717048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation.
    Stoof JC; Verheijden PF; Leysen JE
    Brain Res; 1987 Oct; 423(1-2):364-8. PubMed ID: 2823991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a D2 dopamine receptor in frog retina that decreases cyclic AMP accumulation and serotonin N-acetyltransferase activity.
    Iuvone PM
    Life Sci; 1986 Jan; 38(4):331-42. PubMed ID: 2418326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
    Kelly E; Nahorski SR
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum.
    Battaglia G; Norman AB; Hess EJ; Creese I
    Neurosci Lett; 1985 Aug; 59(2):177-82. PubMed ID: 2932659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices.
    Pizzi M; Da Prada M; Valerio A; Memo M; Spano PF; Haefely WE
    Brain Res; 1988 Jul; 456(2):235-40. PubMed ID: 2974746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of adenylate cyclase inhibition in dopamine autoreceptor regulation of tyrosine hydroxylase in rat nucleus accumbens.
    Onali P; Olianas MC
    Neurosci Lett; 1989 Jul; 102(1):91-6. PubMed ID: 2571111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptors mediating inhibition of the cyclic adenosine monophosphate generating system in the rat renal cortex.
    Ricci A; Collier WL; Rossodivita I; Amenta F
    J Auton Pharmacol; 1991 Apr; 11(2):121-7. PubMed ID: 1675217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-dependent cyclic AMP generating system in chick retina and its relation to melatonin biosynthesis.
    Zawilska JB; Derbiszewska T; Sek B; Nowak JZ
    Neurochem Int; 1995 Dec; 27(6):535-43. PubMed ID: 8574183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of rat retinal dopamine receptors.
    Qu ZX; Fertel R; Neff NH; Hadjiconstantinou M
    J Pharmacol Exp Ther; 1989 Feb; 248(2):621-5. PubMed ID: 2493095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390.
    Serra G; Collu M; Gessa GL
    Psychopharmacology (Berl); 1987; 91(3):330-3. PubMed ID: 2882540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCH 23390 blocks D-1 and D-2 dopamine receptors in rat neostriatum in vitro.
    Plantjé JF; Daus FJ; Hansen HA; Stoof JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):180-2. PubMed ID: 6208489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of inactivation of D1 dopamine receptors on stereotypic and thermic responses to quinpirole (LY 171555).
    Double KL; Crocker AD
    Neurosci Lett; 1990 Jul; 115(1):81-5. PubMed ID: 1977110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization.
    Bates MD; Senogles SE; Bunzow JR; Liggett SB; Civelli O; Caron MG
    Mol Pharmacol; 1991 Jan; 39(1):55-63. PubMed ID: 1846220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-2 dopaminergic agonists and adenosine 3',5'-monophosphate directly regulate the synthesis of alpha-melanocyte-stimulating hormone-like peptides by cultured rat melanotrophs.
    Beaulieu M; Felder R; Kebabian JW
    Endocrinology; 1986 Mar; 118(3):1032-9. PubMed ID: 2419116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.